Ovarian cancer--can intraperitoneal therapy be regarded as new standard in Germany?

A du Bois; B Schmalfeldt; W Meier; J Sehouli; J Pfisterer; Arbeitsgemeinschaft Gynaekologische Onkologie [AGO] Kommission OVAR

doi:10.1111/j.1525-1438.2006.00712.x

Ovarian cancer--can intraperitoneal therapy be regarded as new standard in Germany?

A du Bois
B Schmalfeldt
W Meier
J Sehouli
J Pfisterer
Arbeitsgemeinschaft Gynaekologische Onkologie [AGO] Kommission OVAR

Related Research units

Department of Gynecology

Abstract

The German Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) and the two German cooperative study groups (AGO-OVAR and NOGGO) performed a review of the currently available literature on intraperitoneal first-line treatment in advanced ovarian cancer to consider if this new option should be incorporated into the German guidelines for treatment of ovarian cancer.

Bibliographical data

Original language	English
ISSN	1048-891X
DOIs	https://doi.org/10.1111/j.1525-1438.2006.00712.x
Publication status	Published - 03.10.2006

PubMed	17009967